<html lang="en">
<head>
<meta charset="utf-8"/>
<title offset="1069">Gamma-butyrobetaine dioxygenase</title>
<script src="https://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_SVG.js" type="text/javascript">
</script>
</head>
<body>
<h1>Gamma-butyrobetaine dioxygenase</h1>
<hr/>

<p><strong>Gamma-butyrobetaine dioxygenase</strong> (also known as BBOX, GBBH or γ-butyrobetaine hydroxylase) is an <a class="uri" href="enzyme" title="wikilink">enzyme</a> that in humans is encoded by the <em>BBOX1</em> <a class="uri" href="gene" title="wikilink">gene</a>.<a class="footnoteRef" href="#fn1" id="fnref1"><sup>1</sup></a><a class="footnoteRef" href="#fn2" id="fnref2"><sup>2</sup></a> Gamma-butyrobetaine dioxygenase catalyses the formation of <a class="uri" href="L-carnitine" title="wikilink">L-carnitine</a> from gamma-butyrobetaine, the last step in the L-<a href="carnitine_biosynthesis" title="wikilink">carnitine biosynthesis</a> pathway.<a class="footnoteRef" href="#fn3" id="fnref3"><sup>3</sup></a> <a class="uri" href="Carnitine" title="wikilink">Carnitine</a> is essential for the transport of activated <a href="fatty_acid" title="wikilink">fatty acids</a> across the <a href="mitochondrial_membrane" title="wikilink">mitochondrial membrane</a> during mitochondrial <a href="beta_oxidation" title="wikilink">beta oxidation</a>.<a class="footnoteRef" href="#fn4" id="fnref4"><sup>4</sup></a> In humans, gamma-butyrobetaine dioxygenase can be found in kidney (high), liver (moderate), and brain (very low).<a class="footnoteRef" href="#fn5" id="fnref5"><sup>5</sup></a><a class="footnoteRef" href="#fn6" id="fnref6"><sup>6</sup></a> <em>BBOX1</em> has recently been identified as a potential <a class="uri" href="cancer" title="wikilink">cancer</a> <a class="uri" href="gene" title="wikilink">gene</a> on the basis of a large-scale <a class="uri" href="microarray" title="wikilink">microarray</a> data analysis.<a class="footnoteRef" href="#fn7" id="fnref7"><sup>7</sup></a></p>
<h2 id="reaction">Reaction</h2>

<p>The following reaction is catalyzed by gamma-butyrobetaine dioxygenase:</p>
<dl>
<dd>4-trimethylammoniobutanoate (γ-butyrobetaine) + <a class="uri" href="2-oxoglutarate" title="wikilink">2-oxoglutarate</a> + O<sub>2</sub> 

<math display="inline" id="Gamma-butyrobetaine_dioxygenase:0">
 <semantics>
  <mo>⇌</mo>
  <annotation-xml encoding="MathML-Content">
   <ci>normal-⇌</ci>
  </annotation-xml>
  <annotation encoding="application/x-tex">
   \rightleftharpoons
  </annotation>
 </semantics>
</math>

 3-hydroxy-4-trimethylammoniobutanoate (<a class="uri" href="L-carnitine" title="wikilink">L-carnitine</a>) + <a class="uri" href="succinate" title="wikilink">succinate</a> + CO<sub>2</sub>
</dd>
</dl>

<p>The three <a href="substrate_(biochemistry)" title="wikilink">substrates</a> of this enzyme are 4-trimethylammoniobutanoate (γ-butyrobetaine), <a class="uri" href="2-oxoglutarate" title="wikilink">2-oxoglutarate</a>, and <a href="oxygen" title="wikilink">O<sub>2</sub></a>,<a class="footnoteRef" href="#fn8" id="fnref8"><sup>8</sup></a> whereas its three <a href="product_(chemistry)" title="wikilink">products</a> are 3-hydroxy-4-trimethylammoniobutanoate (<a class="uri" href="L-carnitine" title="wikilink">L-carnitine</a>), <a class="uri" href="succinate" title="wikilink">succinate</a>, and <a href="carbon_dioxide" title="wikilink">carbon dioxide</a>.</p>

<p>This enzyme belongs to the family of <a href="oxidoreductase" title="wikilink">oxidoreductases</a>, specifically those acting on paired donors, with O<sub>2</sub> as oxidant and incorporation or reduction of oxygen. The oxygen incorporated need not be derived from O<sub>2</sub> with 2-oxoglutarate as one donor, and incorporation of one atom of oxygen into each donor. This enzyme participates in <a href="lysine_degradation" title="wikilink">lysine degradation</a>. <a class="uri" href="Iron" title="wikilink">Iron</a> is a <a href="cofactor_(biochemistry)" title="wikilink">cofactor</a> for gamma-butyrobetaine dioxygenase. Similar to many other <a href="2-oxoglutarate" title="wikilink">2OG</a> <a class="uri" href="oxygenases" title="wikilink">oxygenases</a>, the activity of gamma-butyrobetaine dioxygenase can be stimulated by <a href="reducing_agents" title="wikilink">reducing agents</a> such as <a class="uri" href="ascorbate" title="wikilink">ascorbate</a> and <a class="uri" href="glutathione" title="wikilink">glutathione</a>.<a class="footnoteRef" href="#fn9" id="fnref9"><sup>9</sup></a><a class="footnoteRef" href="#fn10" id="fnref10"><sup>10</sup></a><a class="footnoteRef" href="#fn11" id="fnref11"><sup>11</sup></a><a class="footnoteRef" href="#fn12" id="fnref12"><sup>12</sup></a> The catalytic activity of gamma-butyrobetaine dioxygenase can be stimulated with different metal ions, especially potassium ions.<a class="footnoteRef" href="#fn13" id="fnref13"><sup>13</sup></a></p>

<p>Both the <em>apo</em> (PDB id: 3N6W)<a class="footnoteRef" href="#fn14" id="fnref14"><sup>14</sup></a> and the <em>holo</em> (PDB id: 3O2G)<a class="footnoteRef" href="#fn15" id="fnref15"><sup>15</sup></a> structures of gamma-butyrobetaine dioxygenase have been solved, demonstrating an <a href="induced_fit" title="wikilink">induced fit</a> mechanism may contribute to the catalytic activity of gamma-butyrobetaine dioxygenase.</p>

<p>Gamma-butyrobetaine dioxygenase is <a href="enzyme_promiscuity" title="wikilink">promiscus</a> in substrate selectivity and it processes a number of modified substrates, including the natural catalytic products <a class="uri" href="L-carnitine" title="wikilink">L-carnitine</a> and D-<a class="uri" href="carnitine" title="wikilink">carnitine</a>, forming <a class="uri" href="3-dehydrocarnitine" title="wikilink">3-dehydrocarnitine</a> and trimethylaminoacetone.<a class="footnoteRef" href="#fn16" id="fnref16"><sup>16</sup></a><a class="footnoteRef" href="#fn17" id="fnref17"><sup>17</sup></a> Gamma-butyrobetaine dioxygenase also catalyses the oxidation of <a class="uri" href="mildronate" title="wikilink">mildronate</a><a class="footnoteRef" href="#fn18" id="fnref18"><sup>18</sup></a> to form multiple products including malonic acid semialdehyde, <a class="uri" href="dimethylamine" title="wikilink">dimethylamine</a>, <a class="uri" href="formaldehyde" title="wikilink">formaldehyde</a> and (1-methylimidazolidin-4-yl)acetic acid, which is proposed to be formed via a <a href="Stevens_rearrangement" title="wikilink">Stevens rearrangement</a> mechanism.<a class="footnoteRef" href="#fn19" id="fnref19"><sup>19</sup></a><a class="footnoteRef" href="#fn20" id="fnref20"><sup>20</sup></a> Gamma-butyrobetaine dioxygenase is unique among other human <a href="2-oxoglutarate" title="wikilink">2OG</a> <a class="uri" href="oxygenases" title="wikilink">oxygenases</a> that it catalyses both <a class="uri" href="hydroxylation" title="wikilink">hydroxylation</a> (e.g.: <a class="uri" href="L-carnitine" title="wikilink">L-carnitine</a>), <a class="uri" href="demethylation" title="wikilink">demethylation</a> (e.g.: formaldehyde) and <a href="C-C_bond" title="wikilink">C-C bond</a> formation (e.g.: (1-methylimidazolidin-4-yl)acetic acid).<a class="footnoteRef" href="#fn21" id="fnref21"><sup>21</sup></a> </p>
<h2 id="inhibition">Inhibition</h2>

<p>Gamma-butyrobetaine dioxygenase is an inhibition target for 3-(2,2,2-trimethylhydraziniumyl)propionate (<a class="uri" href="mildronate" title="wikilink">mildronate</a>, also known as THP, MET-88, Meldonium or Quarterine). Mildronate is clinically used for the treatments of <a class="uri" href="angina" title="wikilink">angina</a> and <a href="myocardial_infarction" title="wikilink">myocardial infarction</a>.<a class="footnoteRef" href="#fn22" id="fnref22"><sup>22</sup></a><a class="footnoteRef" href="#fn23" id="fnref23"><sup>23</sup></a><a class="footnoteRef" href="#fn24" id="fnref24"><sup>24</sup></a> Some studies suggested that mildronate may also be beneficial for the treatment of <a href="neurological_disorder" title="wikilink">neurological disorder</a>,<a class="footnoteRef" href="#fn25" id="fnref25"><sup>25</sup></a><a class="footnoteRef" href="#fn26" id="fnref26"><sup>26</sup></a> <a class="uri" href="diabetes" title="wikilink">diabetes</a>,<a class="footnoteRef" href="#fn27" id="fnref27"><sup>27</sup></a> and <a class="uri" href="seizures" title="wikilink">seizures</a> and <a href="alcohol_intoxication" title="wikilink">alcohol intoxication</a>.<a class="footnoteRef" href="#fn28" id="fnref28"><sup>28</sup></a> Mildronate is currently manufactured and marketed by <a class="uri" href="Grindeks" title="wikilink">Grindeks</a>, a pharmaceutical company based in <a class="uri" href="Latvia" title="wikilink">Latvia</a>. To date, at least five <a href="clinical_trial" title="wikilink">clinical trial</a> reports were <a href="Academic_publishing" title="wikilink">published</a> in <a href="Academic_journal" title="wikilink">peer-reviewed journals</a> documenting the <a class="uri" href="efficacy" title="wikilink">efficacy</a> and <a href="Pharmacovigilance" title="wikilink">safety</a> of mildronate on the treatments of <a class="uri" href="angina" title="wikilink">angina</a>, <a class="uri" href="stroke" title="wikilink">stroke</a> and <a href="chronic_heart_failure" title="wikilink">chronic heart failure</a>.<a class="footnoteRef" href="#fn29" id="fnref29"><sup>29</sup></a><a class="footnoteRef" href="#fn30" id="fnref30"><sup>30</sup></a><a class="footnoteRef" href="#fn31" id="fnref31"><sup>31</sup></a><a class="footnoteRef" href="#fn32" id="fnref32"><sup>32</sup></a><a class="footnoteRef" href="#fn33" id="fnref33"><sup>33</sup></a></p>

<p>Mildronate has a similar structure to the natural substrate gamma-butyrobetaine, with a NH group replacing the CH<sub>2</sub> of gamma-butyrobetaine at the C-4 position. A crystal structure of mldronate in complex with gamma-butyrobetaine dioxygenase was published, and it suggests mildronate bind to gamma-butyrobetaine dioxygenase in exactly the same way as gamma-butyrobetaine (PDB id: 3MS5).<a class="footnoteRef" href="#fn34" id="fnref34"><sup>34</sup></a> To date, most <a href="enzyme_inhibitors" title="wikilink">enzyme inhibitors</a> for human <a href="oxoglutarate_dehydrogenase_complex" title="wikilink">2OG</a> <a class="uri" href="oxygenases" title="wikilink">oxygenases</a> bind to the cosubstrate 2OG <a href="binding_site" title="wikilink">binding site</a>; mildronate is a rare example of a non-peptidyl substrate mimic inhibitor.<a class="footnoteRef" href="#fn35" id="fnref35"><sup>35</sup></a> Although initial reports suggested mildronate is a <a class="uri" href="non-competitive" title="wikilink">non-competitive</a> and non-hydroxylatable analogue of gamma-butyrobetaine,<a class="footnoteRef" href="#fn36" id="fnref36"><sup>36</sup></a> further studies have identified mildronate is indeed a substrate for gamma-butyrobetaine dioxygenase.<a class="footnoteRef" href="#fn37" id="fnref37"><sup>37</sup></a><a class="footnoteRef" href="#fn38" id="fnref38"><sup>38</sup></a><a class="footnoteRef" href="#fn39" id="fnref39"><sup>39</sup></a></p>

<p>Similar to other <a href="2-oxoglutarate" title="wikilink">2OG</a> <a class="uri" href="oxygenases" title="wikilink">oxygenases</a>, gamma-butyrobetaine dioxygenase can be inhibited by <a href="2-oxoglutarate" title="wikilink">2OG</a> mimics and aromatic inhibitors such as pyridine 2,4-dicarboxylate.<a class="footnoteRef" href="#fn40" id="fnref40"><sup>40</sup></a> Other reported gamma-butyrobetaine dioxygenase inhibitors include cyclopropyl-substituted gamma-butyrobetaines<a class="footnoteRef" href="#fn41" id="fnref41"><sup>41</sup></a> and 3-(2,2-dimethylcyclopropyl)propanoic acid, which is a mechanism-based enzyme inhibitor.<a class="footnoteRef" href="#fn42" id="fnref42"><sup>42</sup></a></p>
<h2 id="assay">Assay</h2>

<p>Several <em><a href="in_vitro" title="wikilink">in vitro</a></em> biochemical <a class="uri" href="assays" title="wikilink">assays</a> have been applied to monitor the catalytic activity of gamma-butyrobetaine dioxygenase. Early methods have mainly focused on the use of <a class="uri" href="radiolabeled" title="wikilink">radiolabeled</a> compounds, including <sup>14</sup>C-labelled gamma-butyrobetaine<a class="footnoteRef" href="#fn43" id="fnref43"><sup>43</sup></a> and <sup>14</sup>C-labelled <a href="2-oxoglutarate" title="wikilink">2OG</a>.<a class="footnoteRef" href="#fn44" id="fnref44"><sup>44</sup></a> <a class="uri" href="Enzyme" title="wikilink">Enzyme</a>-coupled method have also been applied to detect <a class="uri" href="carnitine" title="wikilink">carnitine</a> formation, by using the enzyme <a href="carnitine_acetyltransferase" title="wikilink">carnitine acetyltransferase</a> and <sup>14</sup>C-labelled acetyl-coenzyme A to give labelled acetylcarnitine for detection. Using this method, it is possible to detect <a class="uri" href="carnitine" title="wikilink">carnitine</a> concentration down to the <a href="Pico-" title="wikilink">pico</a>-molar range.<a class="footnoteRef" href="#fn45" id="fnref45"><sup>45</sup></a><a class="footnoteRef" href="#fn46" id="fnref46"><sup>46</sup></a><a class="footnoteRef" href="#fn47" id="fnref47"><sup>47</sup></a> Other analytical methods including <a href="mass_spectrometry" title="wikilink">mass spectrometry</a> and <a class="uri" href="NMR" title="wikilink">NMR</a> have also been applied,<a class="footnoteRef" href="#fn48" id="fnref48"><sup>48</sup></a> and they are in particularly useful for the study of the coupling ratio between <a href="2-oxoglutarate" title="wikilink">2OG</a> <a class="uri" href="oxidation" title="wikilink">oxidation</a> and <a href="substrate_(biochemistry)" title="wikilink">substrate</a> formation, and for the characterisation of unknown enzymatic products.<a class="footnoteRef" href="#fn49" id="fnref49"><sup>49</sup></a> However, these methods are often not suitable for <a href="high-throughput_screening" title="wikilink">high-throughput</a> screening and require <a class="uri" href="expensive" title="wikilink">expensive</a> <a class="uri" href="instrumentation" title="wikilink">instrumentation</a>. A potentially <a href="high-throughput_screening" title="wikilink">high-throughput</a> <a class="uri" href="fluorescence" title="wikilink">fluorescence</a>-based assay has also been proposed by using a fluorinated-gamma-butyrobetaine <a href="Functional_analog" title="wikilink">analogue</a>.<a class="footnoteRef" href="#fn50" id="fnref50"><sup>50</sup></a> The <a class="uri" href="fluoride" title="wikilink">fluoride</a> ions released as a result of gamma-butyrobetaine dioxygenase catalyses can be detected by using chemosensors such as protected <a class="uri" href="fluorescein" title="wikilink">fluorescein</a>.<a class="footnoteRef" href="#fn51" id="fnref51"><sup>51</sup></a></p>
<h2 id="see-also">See also</h2>
<ul>
<li><a class="uri" href="Carnitine" title="wikilink">Carnitine</a></li>
<li><a class="uri" href="Mildronate" title="wikilink">Mildronate</a></li>
<li><a href="Carnitine_biosynthesis" title="wikilink">Carnitine biosynthesis</a></li>
<li><a href="Beta_Oxidation" title="wikilink">Beta Oxidation</a></li>
<li><a href="Fatty_acid_metabolism" title="wikilink">Fatty acid metabolism</a></li>
<li><a href="Stevens_rearrangement" title="wikilink">Stevens rearrangement</a></li>
</ul>
<h2 id="references">References</h2>
<h2 id="further-reading">Further reading</h2>
<ul>
<li></li>
<li></li>
<li></li>
<li></li>
<li></li>
<li></li>
<li></li>
</ul>

<p>"</p>

<p><a href="Category:Human_2OG_oxygenases" title="wikilink">Category:Human 2OG oxygenases</a> <a href="Category:EC_1.14.11" title="wikilink">Category:EC 1.14.11</a> <a href="Category:Iron_enzymes" title="wikilink">Category:Iron enzymes</a> <a href="Category:Ascorbate_enzymes" title="wikilink">Category:Ascorbate enzymes</a></p>
<section class="footnotes">
<hr/>
<ol>
<li id="fn1"><a href="#fnref1">↩</a></li>
<li id="fn2"><a href="#fnref2">↩</a></li>
<li id="fn3"><a href="#fnref3">↩</a></li>
<li id="fn4"></li>
<li id="fn5"></li>
<li id="fn6"><a href="#fnref6">↩</a></li>
<li id="fn7"><a href="#fnref7">↩</a></li>
<li id="fn8"><a href="#fnref8">↩</a></li>
<li id="fn9"><a href="#fnref9">↩</a></li>
<li id="fn10"><a href="#fnref10">↩</a></li>
<li id="fn11"><a href="#fnref11">↩</a></li>
<li id="fn12"><a href="#fnref12">↩</a></li>
<li id="fn13"><a href="#fnref13">↩</a></li>
<li id="fn14">;<a href="#fnref14">↩</a></li>
<li id="fn15">; <a href="#fnref15">↩</a></li>
<li id="fn16"></li>
<li id="fn17"><a href="#fnref17">↩</a></li>
<li id="fn18"><a href="#fnref18">↩</a></li>
<li id="fn19"><a href="#fnref19">↩</a></li>
<li id="fn20"><a href="#fnref20">↩</a></li>
<li id="fn21"><a href="#fnref21">↩</a></li>
<li id="fn22"><a href="#fnref22">↩</a></li>
<li id="fn23"><a href="#fnref23">↩</a></li>
<li id="fn24"><a href="#fnref24">↩</a></li>
<li id="fn25"><a href="#fnref25">↩</a></li>
<li id="fn26"><a href="#fnref26">↩</a></li>
<li id="fn27"><a href="#fnref27">↩</a></li>
<li id="fn28"><a href="#fnref28">↩</a></li>
<li id="fn29"><a href="#fnref29">↩</a></li>
<li id="fn30"><a href="#fnref30">↩</a></li>
<li id="fn31"><a href="#fnref31">↩</a></li>
<li id="fn32"><a href="#fnref32">↩</a></li>
<li id="fn33"><a href="#fnref33">↩</a></li>
<li id="fn34"><a href="#fnref34">↩</a></li>
<li id="fn35"><a href="#fnref35">↩</a></li>
<li id="fn36"><a href="#fnref36">↩</a></li>
<li id="fn37"></li>
<li id="fn38"></li>
<li id="fn39"><a href="#fnref39">↩</a></li>
<li id="fn40"><a href="#fnref40">↩</a></li>
<li id="fn41"><a href="#fnref41">↩</a></li>
<li id="fn42"><a href="#fnref42">↩</a></li>
<li id="fn43"><a href="#fnref43">↩</a></li>
<li id="fn44"><a href="#fnref44">↩</a></li>
<li id="fn45"><a href="#fnref45">↩</a></li>
<li id="fn46"><a href="#fnref46">↩</a></li>
<li id="fn47"><a href="#fnref47">↩</a></li>
<li id="fn48"></li>
<li id="fn49"></li>
<li id="fn50"><a href="#fnref50">↩</a></li>
<li id="fn51"><a href="#fnref51">↩</a></li>
</ol>
</section>
</body>
</html>
